This page will bring together all the PrescQIPP care homes resources and showcase good practice examples of projects focusing on medicines optimisation in the care homes setting. Each set of resources contains tools that can be adapted for local use before implementation.
Medication in care homes
Care Homes Webkit webinarThis webinar showcased the work we have done so far on Care homes and future plans.
B66: Bulk PrescribingThe bulk prescribing bulletin and briefing give some general advice on the implementation of bulk prescribing for those organisations wishing to do so. Implementation packs for care homes, GPs and Pharmacists provide the tools that would be needed to support the safe and effective implementation of bulk prescribing.
B72: Homely remedies
The homely remedies resources provide advice on implementing a homely remedies policy in care homes. Support tools include advice on implementation, audit tools, agreement forms and information for GPs.
B143: Supporting self administration of medication in the care home
This bulletin supports the implementation self administration of medicines in the care home setting for of residents who are able to. Assessment and implementation tools are provided to support change and an educational slideset is available to support discussion with care home staff.
B151: How to use multidisciplinary teams effectively
These resources will support effective working and communication between members of a multidisciplinary teams for care home residents.
B75: Controlled drugs good practice guide
This bulletin is intended to be a supporting guidance document for care home staff on the management of CDs in the care home setting. It can be adapted by care home staff to form a policy for use in individual care homes.
B87: Medication and falls
This resource pack has been produced to raise awareness amongst healthcare professionals of
the medicines that can increase the risk of falls in older people. The aim is that they are taken into consideration when conducting medication reviews and also when deciding whether to initiate medicines if the patient is a known faller or at risk of falls. They can be used both for the care homes setting and outside this setting.
Resources include a medicines and falls risk classification document and key information sheet for GPs, an information sheet for care home staff and a falls risk questionnaire.
B93: Waste reduction
This good practice guide to help reduce waste is aimed at GP practices and care home staff. It provides useful tips to consider when generating prescriptions and when ordering and administering medicines.
B112: Good practice guide to prescribing and medication review
The document covers good practice considerations when prescribing and also for medication review. It suggests appropriate times to begin the medication ordering process for the repeat medication cycle in a care home and also advise on considerations for acute prescribing, review of medicines and medicines reconciliation.
B101: Covert administration
The administration of medicines can present challenges in the care home setting, especially where patients refuse to take medicines or are unable to take their medicines. The resources in this section explore some of these challenges and provide guidance on dealing with them.
Coming soon: Transfer of care
There are often issues when patients are transferred to and from care homes settings as communication can be poor and healthcare professionals/care homes staff do not routinely receive the information they need to ensure continuity of care is seamless. The resources in this section explore some of these issues and provide resources to support good practice
Although the use of thickeners is not just associated with care homes, there are particular concerns around the use of these products in care homes. These resources provide guidance on safe and appropriate use and encourage regular review and ensuring training of staff involved in administering thickeners.
Shared care home resources
This section brings together resources to support medicines optimisation in care homes that have been produced by commissioners.
Innovation award winner 2013: Optimising the use of inhalers in the care homes setting
Optimising the use of inhalers in the care homes setting webinar
Innovation award winner 2014: Tool to support Parkinson’s patients in care homes
Tool to support Parkinson’s patients in care homes webinar
Other care homes projects
Reducing Antipsychotic use in Dementia
The use of antipsychotics in dementia to control behavioural and psychological symptoms has been a concern for many years. The PrescQIPP toolkit looks at the safety issues associated with using antipsychotics in this way and also provides practical tools and guidance to support the reduction of use. The toolkit is not just aimed at care homes, however is an important resource to include in the care homes webkit.
T7: Reducing antipsychotics in dementia toolkitThe reducing antipsychotic prescribing in dementia toolkit is a resource aimed at healthcare professionals and carers, which can be used to support the management of behavioural and psychological symptoms of dementia without the use of antipsychotics.
The toolkit contains resources to support assessment of symptoms and non-pharmacological treatment in these patients and also resources to support the reduction in antipsychotic prescribing in those already being prescribed these drugs.
Reducing antipsychotics in dementia webinarThis webinar showcased the resources in the reducing antipsychotics in dementia toolkit and discussed the evidence behind the recommendations.
Integrated care home dementia videoThe video offers expertise from Shane Gordon, North East Essex CCG, Sally Standley, Eastern Academic Health Science Network, Sarah Robinson, NHS England, Carol Roberts, PrescQIPP Strategic Lead, and, the staff involved in delivering and benefiting from two projects in Essex and Norfolk.
The video provides a real 360 view of the projects, their achievements, how they were established and the real benefits they have made to homes dealing with patients on low dose anti-psychotics, and the quality of life for the patients themselves.